title: Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma.
abstract: Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We report a case of HCV-associated stage IV DLBCL successfully treated concurrently using chemoimmunotherapy and a sofosbuvir-based antiviral regimen.
authors.affiliation: Department of Medicine.
authors.forename: Evan C
authors.initials: EC
authors.lastname: Ewers
authors.affiliation: Department of Medicine.
authors.forename: Phalgoon A
authors.initials: PA
authors.lastname: Shah
authors.affiliation: Section of Hematology/Oncology, Department of Medicine, and.
authors.forename: Mark G
authors.initials: MG
authors.lastname: Carmichael
authors.affiliation: Section of Infectious Diseases, Department of Medicine, Tripler Army Medical Center , Honolulu, Hawaii.
authors.forename: Tomas M
authors.initials: TM
authors.lastname: Ferguson
keywords: DLBCL; Hepatitis C Virus; Lymphoma; Sofosbuvir.